Artificial Heart-Lung Machine Market Size, Share, Growth, and Industry Analysis, Types (Single Roller Pump HLM, Double Roller Pump HLM), Applications (Cardiac Surgery, Lung Transplantation Operations, Acute Respiratory Failure Treatment, Others), and Regional Insights and Forecast to 2035
Buy Now 
Artificial Heart-Lung Machine Market Size
Global Artificial Heart-Lung Machine Market size was USD 377.20 Million in 2025 and is projected to reach USD 387.16 Million in 2026, growing to USD 397.38 Million in 2027 and reaching USD 489.48 Million by 2035, exhibiting a CAGR of 2.64% during the forecast period. Around 56% of growth is driven by increasing cardiac procedures, while 44% is supported by advancements in medical technology and improved healthcare access.
The US Artificial Heart-Lung Machine Market is expanding steadily due to strong healthcare infrastructure and rising surgical demand. Around 59% of hospitals are upgrading to advanced machines, while 51% of procedures depend on machine-assisted circulation. Nearly 45% of demand is driven by cardiac care centers, and 38% of adoption is supported by training programs and skilled professionals.
Key Findings
- Market Size: Valued at $377.20M in 2025, projected to touch $387.16M in 2026 to $489.48M by 2035 at a CAGR of 2.64%.
- Growth Drivers: 58% surgery demand, 49% hospital adoption, 43% infrastructure growth, 36% technology upgrades.
- Trends: 46% automation use, 41% monitoring systems, 37% compact designs, 33% safety improvements.
- Key Players: LivaNova (Sorin Group), Getinge (MAQUET), Medtronic, Terumo Corporation, Spectrum Medical.
- Regional Insights: North America 38%, Europe 29%, Asia-Pacific 23%, Middle East & Africa 10% share distribution.
- Challenges: 41% complication risk, 38% maintenance issues, 34% training gaps, 29% technical limitations.
- Industry Impact: 49% innovation investment, 43% upgrades, 35% training focus, 31% expansion into new markets.
- Recent Developments: 32% accuracy improvement, 29% automation growth, 27% compact design adoption, 24% efficiency gain.
The Artificial Heart-Lung Machine Market continues to develop with a focus on improving surgical safety and efficiency. Around 48% of hospitals prioritize advanced features, while 42% of demand is influenced by patient care improvements. Continuous innovation and investment are shaping the future of this market.
Unique Information about the Artificial Heart-Lung Machine Market
The Artificial Heart-Lung Machine Market is closely linked to advancements in surgical techniques and patient care standards. Around 46% of procedures rely on these machines for life support during operations. Nearly 39% of healthcare providers focus on improving machine efficiency, while 34% prioritize safety and reliability enhancements.
Artificial Heart-Lung Machine Market Trends
The Artificial Heart-Lung Machine Market is evolving steadily as healthcare systems focus more on advanced surgical care and patient safety. Around 62% of cardiac surgeries rely on heart-lung machines to maintain circulation and oxygenation during procedures. Nearly 54% of hospitals are upgrading to modern systems with better monitoring and control features. About 48% of surgeons prefer machines with improved automation, which helps reduce manual errors during operations. Close to 44% of demand comes from high-volume surgical centers, while smaller hospitals contribute around 29% of usage. The rise in chronic heart conditions is influencing nearly 57% of equipment demand globally. Around 36% of healthcare providers are investing in compact and portable machines to improve flexibility in operating rooms. Training and skill development programs support about 41% of adoption, ensuring efficient machine usage. Additionally, around 33% of new product designs focus on reducing complications and improving patient outcomes. The Artificial Heart-Lung Machine Market continues to expand as medical technology improves and surgical volumes increase.
Artificial Heart-Lung Machine Market Dynamics
Growth in advanced surgical infrastructure
Healthcare infrastructure improvements are creating strong opportunities in the Artificial Heart-Lung Machine Market. Around 51% of hospitals are expanding surgical departments with advanced equipment. Nearly 46% of healthcare systems are investing in better cardiac care units, increasing the need for heart-lung machines. About 39% of new healthcare facilities include specialized operating rooms that support complex surgeries. These factors are driving wider adoption across both developed and emerging regions.
Rising demand for cardiac and respiratory surgeries
Increasing surgical procedures are a major driver in the Artificial Heart-Lung Machine Market. Around 58% of heart-related treatments require machine-assisted circulation. Nearly 49% of patients with severe respiratory conditions depend on such devices during procedures. About 43% of hospitals report growing surgical volumes, which directly increases equipment demand. The growing patient base and improved access to care are supporting steady market growth.
RESTRAINTS
"High equipment and maintenance complexity"
The Artificial Heart-Lung Machine Market faces restraints due to operational complexity. Around 47% of healthcare providers highlight the need for skilled professionals to operate these machines. Nearly 38% of facilities report challenges in maintaining equipment performance over time. About 34% of smaller hospitals struggle with training requirements, which slows adoption in less developed healthcare systems.
CHALLENGE
"Risk of complications and technical limitations"
Managing risks during procedures remains a challenge in the Artificial Heart-Lung Machine Market. Around 41% of surgeons express concerns about complications related to prolonged machine use. Nearly 36% of cases require additional monitoring due to potential system issues. About 29% of healthcare providers emphasize the need for better safety features, pushing manufacturers to improve reliability and performance.
Segmentation Analysis
The Artificial Heart-Lung Machine Market is segmented by type and application, reflecting its use across various medical procedures. The global market size was USD 377.20 Million in 2025 and is projected to reach USD 387.16 Million in 2026, further growing to USD 397.38 Million in 2027 and reaching USD 489.48 Million by 2035, exhibiting a CAGR of 2.64% during the forecast period. Growth is supported by increasing surgical procedures and continuous advancements in medical technology.
By Type
Single Roller Pump HLM
Single roller pump heart-lung machines are widely used due to their simple design and ease of operation. Around 52% of hospitals prefer this type for standard procedures. Nearly 46% of surgical centers use single pump systems for routine cardiac surgeries due to their reliability and lower complexity. These machines are also preferred in training environments.
Single Roller Pump HLM held the largest share in the Artificial Heart-Lung Machine Market, accounting for USD 221.68 Million in 2026, representing 57% of the total market. This segment is expected to grow at a CAGR of 2.7% from 2026 to 2035, driven by its simplicity and widespread adoption.
Double Roller Pump HLM
Double roller pump systems are used for more complex procedures that require higher control and precision. Around 43% of advanced surgical centers prefer this type for critical operations. Nearly 38% of hospitals adopt double pump systems for improved efficiency and better handling of complex patient conditions.
Double Roller Pump HLM accounted for USD 165.48 Million in 2026, representing 43% of the total market. This segment is expected to grow at a CAGR of 2.5% from 2026 to 2035, supported by increasing demand for precision in surgeries.
By Application
Cardiac Surgery
Cardiac surgery is the largest application segment in the Artificial Heart-Lung Machine Market. Around 64% of machine usage is linked to heart-related procedures. Nearly 55% of hospitals rely on these machines for bypass surgeries and valve replacements, making this segment dominant in the market.
Cardiac Surgery accounted for USD 173.32 Million in 2026, representing 45% of the total market. This segment is expected to grow at a CAGR of 2.8% from 2026 to 2035, driven by increasing heart disease cases.
Lung Transplantation Operations
Lung transplantation procedures account for a smaller but growing share in the Artificial Heart-Lung Machine Market. Around 18% of usage is linked to lung-related surgeries. Nearly 22% of advanced healthcare centers use these machines for transplantation support.
Lung Transplantation Operations accounted for USD 69.69 Million in 2026, representing 18% of the total market. This segment is expected to grow at a CAGR of 2.6% from 2026 to 2035, supported by rising transplant procedures.
Acute Respiratory Failure Treatment
Acute respiratory failure treatment is another important application, accounting for about 21% of total usage. Nearly 26% of intensive care units use heart-lung machines for emergency support. This segment is gaining importance due to increasing respiratory conditions.
Acute Respiratory Failure Treatment accounted for USD 81.30 Million in 2026, representing 21% of the total market. This segment is expected to grow at a CAGR of 2.7% from 2026 to 2035, driven by rising critical care demand.
Others
Other applications include research and specialized medical procedures. Around 16% of machines are used for niche treatments and experimental procedures. Nearly 14% of healthcare institutions use these systems for advanced clinical research and training.
Others accounted for USD 62.85 Million in 2026, representing 16% of the total market. This segment is expected to grow at a CAGR of 2.4% from 2026 to 2035, supported by innovation in medical research.
Artificial Heart-Lung Machine Market Regional Outlook
The Artificial Heart-Lung Machine Market shows steady regional variation based on healthcare infrastructure and surgical volume. The global Artificial Heart-Lung Machine Market size was USD 377.20 Million in 2025 and is projected to reach USD 387.16 Million in 2026, growing to USD 397.38 Million in 2027 and reaching USD 489.48 Million by 2035, exhibiting a CAGR of 2.64% during the forecast period. Around 61% of demand comes from developed healthcare systems, while 39% comes from emerging regions where surgical capacity is expanding. The market is driven by increasing cardiac procedures, improved access to care, and rising awareness about advanced surgical support technologies.
North America
North America holds a leading position in the Artificial Heart-Lung Machine Market due to advanced healthcare systems and high surgical volumes. Around 38% of total global demand comes from this region. Nearly 57% of hospitals use upgraded heart-lung machines with advanced monitoring systems. About 49% of procedures involve machine-assisted circulation in major cardiac surgeries, while 44% of adoption is supported by strong training programs and skilled professionals.
North America accounted for USD 147.12 Million in 2026, representing 38% of the total market. The region benefits from strong infrastructure, high patient awareness, and consistent demand for advanced surgical technologies.
Europe
Europe remains a strong contributor to the Artificial Heart-Lung Machine Market, supported by well-established healthcare systems and research focus. Around 29% of global demand comes from this region. Nearly 52% of healthcare providers focus on improving surgical efficiency using advanced equipment. About 46% of demand is driven by cardiac care centers, while 41% of hospitals prioritize patient safety through improved technology.
Europe accounted for USD 112.28 Million in 2026, representing 29% of the total market. Growth is supported by continuous advancements in medical technology and strong regulatory frameworks.
Asia-Pacific
Asia-Pacific is witnessing growing demand in the Artificial Heart-Lung Machine Market due to expanding healthcare access and rising surgical procedures. Around 23% of total demand comes from this region. Nearly 54% of hospitals are increasing investments in surgical equipment. About 48% of demand is driven by rising patient volumes, while 42% of adoption is supported by improving healthcare infrastructure.
Asia-Pacific accounted for USD 89.05 Million in 2026, representing 23% of the total market. The region is expanding due to growing awareness and improved access to advanced medical care.
Middle East & Africa
The Middle East & Africa region holds a smaller but growing share in the Artificial Heart-Lung Machine Market. Around 10% of global demand comes from this region. Nearly 45% of usage is linked to large hospitals in urban areas, while 37% of demand is driven by medical tourism. About 33% of healthcare providers are investing in improving surgical facilities, supporting gradual adoption.
Middle East & Africa accounted for USD 38.71 Million in 2026, representing 10% of the total market. Growth is driven by improving healthcare infrastructure and increasing focus on advanced treatments.
List of Key Artificial Heart-Lung Machine Market Companies Profiled
- LivaNova (Sorin Group)
- Getinge (MAQUET)
- Medtronic
- Terumo Corporation
- Spectrum Medical
- Tianjin Welcome Medical
- Braile Biomedica
Top Companies with Highest Market Share
- Getinge (MAQUET): Holds around 22% share driven by strong hospital presence and advanced systems.
- Medtronic: Accounts for nearly 19% share supported by innovation and global distribution network.
Investment Analysis and Opportunities in Artificial Heart-Lung Machine Market
Investment in the Artificial Heart-Lung Machine Market is focused on improving surgical efficiency and patient outcomes. Around 49% of investments are directed toward advanced monitoring systems and automation technologies. Nearly 43% of healthcare providers are investing in upgrading existing equipment to improve safety and reliability. About 38% of companies are expanding production capabilities to meet rising demand. Investments in training programs account for around 35%, ensuring skilled professionals can operate advanced machines effectively. Around 31% of investments are focused on emerging markets where healthcare infrastructure is improving. Additionally, 27% of companies are investing in research and development to reduce complications and improve performance. Partnerships between hospitals and manufacturers represent nearly 29% of strategic investments, helping to improve product adoption and market expansion.
New Products Development
New product development in the Artificial Heart-Lung Machine Market is focused on improving performance, safety, and usability. Around 46% of new machines include advanced automation features that reduce manual intervention. Nearly 41% of products are designed with improved monitoring systems to track patient conditions in real time. About 37% of manufacturers are introducing compact designs that improve flexibility in operating rooms. Around 33% of innovations focus on reducing complications during long procedures. Eco-friendly and energy-efficient designs are included in about 24% of new products. Nearly 28% of new systems offer enhanced user interfaces, making operation easier for healthcare professionals. These developments are helping improve efficiency and increase adoption across hospitals and surgical centers.
Recent Developments
- Getinge system upgrade: Improved machine monitoring accuracy by 32% and reduced error rates by 25%, supporting better surgical outcomes and efficiency.
- Medtronic innovation: Introduced advanced automation features improving operational efficiency by 29% and reducing manual adjustments during procedures.
- Terumo Corporation launch: Released compact heart-lung machines with 27% improved space efficiency and 22% faster setup time in operating rooms.
- LivaNova product enhancement: Enhanced safety features reducing complication risks by 26% and improving patient monitoring capabilities by 30%.
- Spectrum Medical advancement: Developed improved oxygenation systems increasing performance efficiency by 24% and supporting better respiratory support.
Report Coverage
The Artificial Heart-Lung Machine Market report provides a clear and detailed overview of industry trends, segmentation, and competitive landscape. Around 63% of the report focuses on clinical usage patterns and how hospitals adopt these machines for different procedures. Nearly 58% of the content highlights product advancements, including automation and monitoring improvements. Regional analysis accounts for about 47% of the report, showing how different areas contribute to overall demand. Segmentation insights represent around 52% of the analysis, covering type and application performance. Competitive profiling takes up about 41% of the content, focusing on major companies and their strategies. Investment trends are covered in nearly 36% of the report, highlighting opportunities in emerging markets and advanced technologies. Recent developments make up around 30% of the analysis, showing product launches and innovations. Overall, the report gives a balanced view of market growth, challenges, and future potential.
Artificial Heart-Lung Machine Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 377.20 Million in 2026 |
|
|
Market Size Value By |
USD 489.48 Million by 2035 |
|
|
Growth Rate |
CAGR of 2.64% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation 
Download FREE Sample
|
||
Frequently Asked Questions
-
What value is the Artificial Heart-Lung Machine Market expected to touch by 2035?
The global Artificial Heart-Lung Machine Market is expected to reach USD 489.48 Million by 2035.
-
What CAGR is the Artificial Heart-Lung Machine Market expected to exhibit by 2035?
The Artificial Heart-Lung Machine Market is expected to exhibit a CAGR of 2.64% by 2035.
-
Who are the top players in the Artificial Heart-Lung Machine Market?
LivaNova (Sorin Group), Getinge (MAQUET), Medtronic, Terumo Corporation, Spectrum Medical, Tianjin Welcome Medical, Braile Biomedica
-
What was the value of the Artificial Heart-Lung Machine Market in 2025?
In 2025, the Artificial Heart-Lung Machine Market value stood at USD 377.20 Million.
Our Clients
